-
1
-
-
0021751383
-
Survival in chronic hepatitis B. An analysis of 379 patients
-
Weissberg JI, Andres LL, Smith CI, et al. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med 1984; 101: 613-616.
-
(1984)
Ann Intern Med
, vol.101
, pp. 613-616
-
-
Weissberg, J.I.1
Andres, L.L.2
Smith, C.I.3
-
2
-
-
0030707941
-
Hepatitis B virus infection
-
Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-1745.
-
(1997)
N Engl J Med
, vol.337
, pp. 1733-1745
-
-
Lee, W.M.1
-
3
-
-
0026527586
-
Acute exacerbations of chronic hepatitis B are accompanied by increased T cell responses to hepatitis core and e antigens
-
Tsai SL, Chen MY, Yang PM, et al. Acute exacerbations of chronic hepatitis B are accompanied by increased T cell responses to hepatitis core and e antigens. J Clin Invest 1992; 89: 87-93.
-
(1992)
J Clin Invest
, vol.89
, pp. 87-93
-
-
Tsai, S.L.1
Chen, M.Y.2
Yang, P.M.3
-
4
-
-
0026663085
-
Hepatitis B-related end-stage liver disease
-
Everhart JE, Hoofnagle J. Hepatitis B-related end-stage liver disease. Gastroenterology 1992; 103: 1692-1694.
-
(1992)
Gastroenterology
, vol.103
, pp. 1692-1694
-
-
Everhart, J.E.1
Hoofnagle, J.2
-
5
-
-
0029893146
-
Long-term follow-up of HBeAg positive patients treated with interferon alfa for chronic hepatitis B
-
Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996; 334: 1422-1427.
-
(1996)
N Engl J Med
, vol.334
, pp. 1422-1427
-
-
Niederau, C.1
Heintges, T.2
Lange, S.3
-
6
-
-
0028887880
-
Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: Outcomes and predictors of response
-
Hope RL, Weltman M, Dingley J, et al. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response. Med J Aust 1995; 162: 8-11.
-
(1995)
Med J Aust
, vol.162
, pp. 8-11
-
-
Hope, R.L.1
Weltman, M.2
Dingley, J.3
-
7
-
-
0030933395
-
Natural history of liver fibrosis progression in patients with chronic hepatitis C
-
Poynard T, Bedossa P, Opolon P, et al. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349: 825-832.
-
(1997)
Lancet
, vol.349
, pp. 825-832
-
-
Poynard, T.1
Bedossa, P.2
Opolon, P.3
-
8
-
-
0031041924
-
Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
-
Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112: 463-472.
-
(1997)
Gastroenterology
, vol.112
, pp. 463-472
-
-
Fattovich, G.1
Giustina, G.2
Degos, F.3
-
9
-
-
17144435206
-
Hepatitis C: A current perspective
-
Farrell GC. Hepatitis C: a current perspective. Aust Fam Physician 1995; 24: 321-329.
-
(1995)
Aust Fam Physician
, vol.24
, pp. 321-329
-
-
Farrell, G.C.1
-
10
-
-
0030928695
-
Hepatitis C: The clinical spectrum of disease
-
Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26 (3 Suppl 1): 15S-20S.
-
(1997)
Hepatology
, vol.26
, Issue.3 SUPPL. 1
-
-
Hoofnagle, J.H.1
-
11
-
-
0028876341
-
Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations
-
Gumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-620.
-
(1995)
Ann Intern Med
, vol.123
, pp. 615-620
-
-
Gumber, S.C.1
Chopra, S.2
-
12
-
-
0023784399
-
Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis
-
Williams AL, Hoofnagle JH. Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterotogy 1988; 95: 734-739.
-
(1988)
Gastroenterotogy
, vol.95
, pp. 734-739
-
-
Williams, A.L.1
Hoofnagle, J.H.2
-
13
-
-
0026042728
-
Treatment of chronic hepatitis B
-
Davis GL. Treatment of chronic hepatitis B. Hepatology 1991; 14: 567-569.
-
(1991)
Hepatology
, vol.14
, pp. 567-569
-
-
Davis, G.L.1
-
14
-
-
0028836094
-
Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation
-
Angus PW, Locarnini SA, McCaughan GW, et al. Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation. Hepatology 1995; 21: 14-18.
-
(1995)
Hepatology
, vol.21
, pp. 14-18
-
-
Angus, P.W.1
Locarnini, S.A.2
McCaughan, G.W.3
-
15
-
-
0030063669
-
Thrombocytopenia associated with hepatitis C viral infection
-
Nagamine T, Ohtuka T, Takehara K, et al. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24: 135-140.
-
(1996)
J Hepatol
, vol.24
, pp. 135-140
-
-
Nagamine, T.1
Ohtuka, T.2
Takehara, K.3
-
16
-
-
0030046698
-
The infected health care provider
-
Gerberding JL. The infected health care provider. N Engl J Med 1996; 334: 594-595.
-
(1996)
N Engl J Med
, vol.334
, pp. 594-595
-
-
Gerberding, J.L.1
-
17
-
-
0028894309
-
Hepatitis induced by traditional Chinese herbs; possible toxic components
-
Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs; possible toxic components. Gut 1995; 36: 146-148.
-
(1995)
Gut
, vol.36
, pp. 146-148
-
-
Kane, J.A.1
Kane, S.P.2
Jain, S.3
-
18
-
-
0030917694
-
Safety issues in herbal medicine: Implications for the health professions
-
Drew AK, Myers SP. Safety issues in herbal medicine: implications for the health professions. Med J Aust 1997; 166: 538-541.
-
(1997)
Med J Aust
, vol.166
, pp. 538-541
-
-
Drew, A.K.1
Myers, S.P.2
-
19
-
-
0027378724
-
Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis
-
Wong DKH, Cheung AM, O'Rourke K, et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 312-323.
-
(1993)
Ann Intern Med
, vol.119
, pp. 312-323
-
-
Wong, D.K.H.1
Cheung, A.M.2
O'Rourke, K.3
-
21
-
-
0030795953
-
Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value
-
Ockenga J, Tillmann HL, Trautwein C, et al. Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value. J Hepatol 1997; 27: 18-24.
-
(1997)
J Hepatol
, vol.27
, pp. 18-24
-
-
Ockenga, J.1
Tillmann, H.L.2
Trautwein, C.3
-
22
-
-
1842291578
-
The treatment of chronic viral hepatitis
-
Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336: 347-356.
-
(1997)
N Engl J Med
, vol.336
, pp. 347-356
-
-
Hoofnagle, J.H.1
Di Bisceglie, A.M.2
-
23
-
-
0028864271
-
Interferon alfa-2b for chronic hepatitis C: Effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial
-
Lin R, Roach E, Zimmerman M, et al. Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. J Hepatol 1995; 23: 487-496.
-
(1995)
J Hepatol
, vol.23
, pp. 487-496
-
-
Lin, R.1
Roach, E.2
Zimmerman, M.3
-
24
-
-
0029833829
-
Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration
-
Poynard T, Leroy V, Cohard M, et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 1996; 24: 778-789.
-
(1996)
Hepatology
, vol.24
, pp. 778-789
-
-
Poynard, T.1
Leroy, V.2
Cohard, M.3
-
25
-
-
0030886964
-
National Institutes of Health Consensus Development Conference Panel Statement: Management of hepatitis C
-
National Institutes of Health Consensus Development Conference Panel Statement: management of hepatitis C. Hepatology 1997; 26 (Suppl 1): 2S-10S.
-
(1997)
Hepatology
, vol.26
, Issue.1 SUPPL.
-
-
-
26
-
-
0030093219
-
Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C
-
Lin R, Liddle C, Byth K, Farrell GC. Virus and host factors are both important determinants of response to interferon treatment among patients with chronic hepatitis C. J Viral Hepatitis 1996; 3: 85-96.
-
(1996)
J Viral Hepatitis
, vol.3
, pp. 85-96
-
-
Lin, R.1
Liddle, C.2
Byth, K.3
Farrell, G.C.4
-
27
-
-
0030039651
-
A survey of adverse effects in 11241 patients with chronic viral hepatitis treated with alfa interferon
-
Fattovich G, Giustina G, Favarato S, et al. A survey of adverse effects in 11241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996; 24: 38-47.
-
(1996)
J Hepatol
, vol.24
, pp. 38-47
-
-
Fattovich, G.1
Giustina, G.2
Favarato, S.3
-
28
-
-
2642602568
-
Recombinant interferon alfa-2b (Intron A) alone or in combination with ribavirin (Rebetol) for retreatment of interferon relapse in chronic hepatitis C
-
submitted
-
Davis GL, Esteban-Mur R, Rustgi V, et al. Recombinant interferon alfa-2b (Intron A) alone or in combination with ribavirin (Rebetol) for retreatment of interferon relapse in chronic hepatitis C. N Engl J Med (submitted).
-
N Engl J Med
-
-
Davis, G.L.1
Esteban-Mur, R.2
Rustgi, V.3
-
29
-
-
16044367618
-
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
-
Grellier L, Mutimer D, Ahmed M, et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet 1996; 348: 1212-1215.
-
(1996)
Lancet
, vol.348
, pp. 1212-1215
-
-
Grellier, L.1
Mutimer, D.2
Ahmed, M.3
-
30
-
-
0031009212
-
Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: Referral patterns and transplant outcomes
-
Levy MT, Chen JJ, McGuinness PH, et al. Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomes. J Gastroenterol Hepatol 1997; 12: 453-459.
-
(1997)
J Gastroenterol Hepatol
, vol.12
, pp. 453-459
-
-
Levy, M.T.1
Chen, J.J.2
McGuinness, P.H.3
-
31
-
-
0029877783
-
Treating small hepatocellular carcinomas
-
Williams R, Rizzi P. Treating small hepatocellular carcinomas. N Engl J Med 1996; 334: 728-729.
-
(1996)
N Engl J Med
, vol.334
, pp. 728-729
-
-
Williams, R.1
Rizzi, P.2
|